YM BioSciences Receives Orphan Drug Designation In EU For Myelofibrosis Treatment

YM BioSciences has received orphan drug designation from the European Commission for CYT387, a treatment for myelofibrosis, a type of chronic leukemia.

Read more »

ReNeuron Treats Third Stroke Patient In Phase I Trials Of Stem Cell Therapy

ReNeuron said this morning the last of the stroke patients in the initial dosing group has been treated with the group’s new stem cell therapy.

Read more »